Objectives: Aortic valve replacement (AVR) in patients with small aortic annulus (diameter ≤21 mm) is considered a challenging scenario because of technical aspects and the high risk of patient-prosthesis mismatch (PPM). The choice of the appropriate prosthesis is crucial, and at the moment, an ideal device has yet to be identified. We compare clinical and hemodynamic results after AVR with three bioprostheses with different design and characteristics. Methods: We retrospectively evaluated 76 consecutive patients from two cardiac surgery centers who underwent AVR (Trifecta = 24; Edwards INTUITY Elite valve system = 26, and Perceval = 26) for severe aortic stenosis between 2013 and 2017. Patients selected were older than 75 years and with an annulus diameter ≤21 mm at preoperative echocardiogram. Reinterventions and combined procedures were excluded. Minimally invasive AVR was performed in 44 (57.8%) patients. Telephonic interview was obtained at 2.9 ± 0.5 years and echocardiographic follow-up at 2.2 ± 0.8 years. Results: Clinical outcome was similar in the three groups. At follow-up, Trifecta patients presented significantly higher peak and mean transprosthetic pressure gradients (P = 0.04 and 0.01). Effective orifice area and left ventricular mass regression were comparable, although an advantage was observed in Perceval patients without reaching the statistical significance. Incidence of moderate (P = 0.2) and severe PPM (P = 0.7) was comparable. Conclusions: Despite higher postoperative pressure gradients observed with the Trifecta valve, all three prostheses (Trifecta, Edwards INTUITY Elite, and Perceval) have proven to be reliable when implanted in small aortic annuli, with good clinical outcome and favorable left ventricular mass regression.
Introduction
Despite the increasing spread of alternative procedures, surgical aortic valve replacement (AVR) is still the gold standard in treatment of severe aortic stenosis. 1 Patients who undergo AVR present a worrying risk of patient-prosthesis mismatch (PPM). PPM, first described by Rahimtoola et al. 2 in 1978, may occur when the effective orifice area (EOA) of the implanted prosthetic valve is too small as related to the body surface area (BSA). PPM is defined moderate when the ratio between the EOA and BSA (EOA-indexed) is ≤0.85 cm 2 /m 2 . Severe PPM occurs when the EOA-index is ≤0.65 cm 2 /m 2 . Frequently, some degree of PPM is observed in patients treated for AVR, with a prevalence of 20% to 70% for moderate PPM and 2% to 10% for severe PPM. [3] [4] [5] The persistent high transprosthetic pressure gradient increases left ventricular workload and reduces the expected left ventricular mass regression. 3, 4, 6 Patients with a small aortic annulus (≤21 mm) undergoing AVR have a higher risk to develop postoperative PPM because of their restricted EOA, especially if they are obese with an elevated BSA. Trifecta (St. Jude Medical, Inc., St. Paul, MN, USA), Edwards INTUITY Elite valve system (Edwards Lifesciences Corp., Irvine, CA, USA), and Perceval-S (LivaNova, London, UK) are three aortic valve bioprostheses with different characteristics but, as described by several authors, with a common good hemodynamic performance in small aortic annuli. 3, [6] [7] [8] [9] [10] [11] [12] The aim of this study is to compare clinical results and hemodynamic performance of the mentioned three bioprostheses in patients with severe aortic stenosis and annulus diameter ≤21 mm.
Methods
This is a retrospective, nonrandomized, two centers' experience (Catholic University of the Sacred Heart, Agostino Gemelli Polyclinic, Rome, Italy and Poliambulanza Foundation Hospital, Brescia, Italy). Between March 2013 and February 2017, 76 consecutive >75-year-old patients presenting with an aortic annulus diameter ≤21 mm at preoperative transthoracic echocardiogram underwent isolated AVR for severe aortic stenosis. Valve prostheses implanted, all in bovine pericardium, were Trifecta (n = 24), INTUITY Elite (n = 26), or Perceval (n = 26), selected according to the surgeon's criteria and preference. Reinterventions and combined procedures were excluded. Operation was performed in mild hypothermia either through a full median sternotomy and aortic and right atrial cannulation or with V-shaped or reversed T-shaped ministernotomy, with central aortic and either central or common femoral vein cannulation. Left ventricular vent was inserted through the right superior pulmonary vein. Myocardial protection was achieved with cold crystalloid or blood cardioplegia. In about half of ministernotomy patients, pulmonary artery venting and retrograde cardioplegia delivering were obtained by using a transjugular Endovent (Edwards Lifesciences Corp., Irvine, CA, USA) and Propledge cannula (Edwards Lifesciences Corp., Irvine, CA, USA), respectively. The native stenotic valve was excised and accurate complete annular decalcification was performed in all patients. After sizing, the valve was replaced with a stented Trifecta prosthesis sutured in supra-annular position by using interrupted pledgeted sutures, or with a rapid deployment INTUITY valve, or with a sutureless Perceval bioprosthesis, the latters implanted according to the instructions-for-use of the manufacturers. Aortotomy was closed with polypropylene running suture. Transesophageal echocardiogram was performed intraoperatively in order to assess regular positioning and correct function of the bioprosthesis implanted. Pre-and postoperative transthoracic echocardiograms were performed by an experienced cardiologist. At 2.9 ± 0.5 years, discharged patients answered phone interview questionnaire and at 2.2 ± 0.8 years, a transthoracic echocardiogram was performed in 64 patients ( 84.2%). Peak and mean pressure gradients were derived from transaortic flow recorded with continuous-wave Doppler. Preoperative aortic valve area (AVA) and postoperative EOA were calculated with the continuity equation and indexed to BSA. Moderate PPM was defined as EOA-index ≤0.85 cm 2 /m 2 , and severe PPM was defined as ≤ 0.65 cm 2 /m 2 . After surgery, patients with Trifecta and INTUITY Elite were treated initially with subcutaneous enoxaparin. Once 2.0 to 2.5 International Normalized Ratio (INR) value was reached, Warfarin anticoagulation was continued for 3 months, followed by lifelong therapy with acetylsalicylic acid. Patients with Perceval were treated only with acetylsalicylic acid as lifelong therapy.
Institutional Review Boards of Agostino Gemelli Polyclinic and Poliambulanza Foundation Hospital approved this study.
Statistical Analysis
Statistical analysis was performed with StartView 4.5 software (Abacus Concepts, Berkeley, CA, USA). Patients were divided in 3 groups according to the prosthesis type (group 1: Trifecta; group 2: INTUITY; group 3: Perceval). Category variables are described as frequencies and in brackets as percentages. Continuous variables are reported as mean ± standard deviation (SD). The Pearson χ 2 test was used to compare categorical variables. Continuous variables were compared with ANOVA/ANCOVA (one-way analysis of variance) with only one independent variable (prosthesis type selected as factor). A Bonferroni post hoc correction was adopted as post hoc test for dependent multiple comparison of continuous variables among three groups. A value of P < 0.05 was considered statistically significant both for category and for continuous variables. For the Bonferroni test, a value of P < 0.0167 was considered statistically significant.
Results
Patient baseline characteristics are summarized in Table 1 . In all groups, patients were older than 75 years (P = 0.6) and presented a high prevalence of female sex (P = 0.4). There was no substantial difference for cardiovascular risk factors, comorbidities, and operative risk scores (Euroscore II: 2.8 ± 1.6%, 2.8 ± 2.2%, and 2.9 ± 2.2% P = 0.9; STS (Society of Thoracic Surgeons) score: 3.9 ± 3%, 3.3 ± 1.7%, and 2.8 ± 1.8%, P = 0.2). At preoperative echocardiogram, AVA, AVA-index, peak pressure gradient (PPG), mean pressure gradient (MPG), left ventricular (LV) mass, LV mass-index, and left ventricular ejection fraction (LVEF) were similar. Patients in the Perceval group had a statistically not significant lower preoperative pressure gradients because 5 of them presented with a low-flow low-gradient aortic stenosis. Intraoperative and early postoperative data are described in Table 2 . A significant difference was observed between the 3 groups in cardiopulmonary bypass time (P = 0.0005) and aortic cross-clamping time (P ≤ 0.0001). Postoperative echocardiogram did not show significant difference in transvalvular pressure gradients among the 3 groups (P = 0.1 and 0.5 for PPG and MPG, respectively). No intra-or paravalvular leaks were observed. Despite no significant difference being found in the incidence of atrial fibrillation, there was a trend toward higher incidence of atrial fibrillation in the INTUITY and in the Perceval groups. Two Perceval patients required early pacemaker implantation. Early postoperative stroke was observed in 2 patients in the INTUITY group. Interestingly, we did not observe a significant reduction of hospitalization length in the sutureless and in the rapid deployment groups compared with the sutured group (intensive care unit days: P = 0.09; overall hospitalization days: P = 0.1). Other early in-hospital events were similar.
At 2.9 ± 0.5 years follow-up (Table 3) , no significant difference either in mortality and clinical status, or in incidence of major cardiac events (myocardial infarction, cerebrovascular accidents), infective endocarditis, and pacemaker implantation was observed.
At 2.2 ± 0.5 years echocardiographic follow-up (Table 4 , Fig. 1 ), as expected, a significant improvement of transprosthetic gradients, EOA, EOA-index, LV mass, and LV mass-index was observed compared with preoperative values (P ≤ 0.0001). There was echocardiographic evidence of severe paravalvular leak in 1 patient who underwent Trifecta AVR. EOA and EOA-index were comparable in the three groups (P = 0. 
Discussion
Currently surgical AVR is the gold standard treatment for patients with severe aortic stenosis.
1 Patients with small aortic annulus (≤21 mm) are exposed to a higher risk of PPM. PPM occurs when the EOA of the implanted prosthesis is too small compared to the patient BSA. A moderate (EOA-index ≤0.85 cm 2 /m 2 ) or a severe (EOA-index ≤0.65 cm 2 /m 2 ) PPM could be associated with higher postoperative pressure gradients. 5, 13 Clinical implications of moderate and severe PPM are controversial. Several authors such as Ruel et al., 14 Hanayama et al. 15 and Blackstone et al. 16 didn't find any evidence of relation between PPM and increased long-term mortality rate and reversed left ventricular remodeling as well. However, most authors 13, [17] [18] [19] [20] [21] [22] believe that PPM is associated with reduced left ventricular remodeling, and increased need of new hospitalization, symptoms, episodes of congestive heart failure, and late mortality.
Although the relationship between PPM and clinical outcome is still controversial, general consensus seems to suggest to avoid the risk of favoring PPM at time of surgery. AVR in patients with small annulus may be challenging and several strategies have been adopted to reduce the risk of PPM.
AVR with a stentless bioprosthesis or aortic root enlargement (e.g., Konno, Manouguian, or Nicks operations) could be effective strategies to improve hemodynamic results. However, implantation of a stentless valve (homograft or xenograft) or aortic root enlargement are technically more difficult and risky procedures. They are best performed with soft and pliable tissues without excessive annular calcifications, thus an uncommon finding in elderly patients with aortic stenosis. Both techniques require longer cardiopulmonary bypass and crossclamping times that can be detrimental in older patients. Therefore, they are associated with higher in-hospital mortality and adverse perioperative outcome.
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Conventional AVR with a stented prosthesis still represents the most common option. Nevertheless, the stent frame, the sewing ring, and the pledgeted sutures in small size prostheses may be flow obstructive and favor some degree of PPM. As an alternative technique for small aortic annulus treatment, despite the unavoidable additional risks related to lifelong anticoagulant therapy, AVR with a small size bileaflet mechanical prosthesis even in older patients has been proposed. 24 Recently sutureless and rapid-deployment bioprostheses have become available, thus expanding the "toolbox" of the cardiac surgeon. In this modified and evolving scenario, the choice of the appropriate prosthesis is crucial, in order to match the design characteristics and hemodynamic properties of the selected prosthesis to the clinical needs and characteristics of the patient. Trifecta, INTUITY Elite, and Perceval have proven to be effective and reliable for AVR in patients with small aortic annuli. 3, [6] [7] [8] [9] [10] [11] [12] 23, [25] [26] [27] [28] The Trifecta valve is made of bovine pericardium with leaflets mounted outside the stent frame to maximize the valve opening area. Since its market introduction in 2010, Trifecta encountered a wide favor among cardiac surgeons for its low profile design, reduced pressure gradients, and lower incidence of PPM as compared to other stented bioprostheses. 6, 7 However, its stent frame and pledgeted sutures still somewhat reduce its effective orifice area.
The INTUITY Elite bioprosthesis is a rapid deployment valve, with an innovative delivery system characterized by a stented bovine (Carpentier-Edwards PERIMOUNT Aortic Heart Valve) bioprosthesis seated in supra-annular position and by a subannular balloon-expandable cloth covered skirt frame. Through this skirt the left ventricle outflow tract is possibly enlarged, blood flow optimized, and postoperative pressure gradients lowered. These characteristics seem to justify its good performance in small annuli with low postoperative gradients and improved left ventricular reverse remodeling. 9 Furthermore, the PERIMOUNT bioprosthesis has a well-known, excellent, long-term durability and it would be reasonable to expect similar durability also for the INTUITY prosthesis. 29 The Perceval-S valve is a completely sutureless bioprosthesis. Differently from the previous two devices, it is characterized by absent conventional stent and sewing ring, with an auto-anchoring system of a thin nitinol frame exploiting its radial forces to allow a perfect and stable adhesion to the internal wall of the aortic root. Despite its larger pericardial leaflets, the hemodynamic performance proved effective even in small annuli, with low postoperative gradients and larger EOA compared to conventional stented valves. 8 As reported by Villa and colleagues, 23 postoperative pressure gradients of small and large prostheses are similar, suggesting that in patients with small annulus the sutureless valve optimizes the blood flow independently from its size.
Sutureless and rapid deployment valves present several advantages. As confirmed in our study, they significantly reduce cardiopulmonary bypass and cross clamping time, thus minimizing the detrimental effects of extracorporeal circulation and cardiac arrest, with obvious benefits in high risk and older patients. [25] [26] [27] Furthermore, because of their easy implantation technique, they seem particularly indicated in patients with unfavorable anatomy (i.e., small and highly calcified annulus, diminutive aortic root, obese patients), and in minimally invasive AVR. Our results with Trifecta, INTUITY, and Perceval prostheses used in three groups of patients with similar characteristics didn't differ significantly from the studies of many other authors analyzing each prosthesis individually, or comparing the clinical and hemodynamic performance of two of them. On the other hand, some other studies report controversial resu lts. 3, [6] [7] [8] 11, 12, 23, [26] [27] [28] 30 Of note, interestingly, our 2.2 ± 0.5 year results for small-sized Trifecta (19 mm and 21 mm) in terms of postoperative gradients and EOA markedly differ from results obtained by Domoto et al., 3 who reported at 1 year lower transprosthetic gradients, larger EOA without incidence of PPM in 39 patients having implanted Trifecta 19 mm. Our results, as confirmed by the Bonferroni analysis, showed significantly higher postoperative PPG and MPG for the Trifecta valve (P: 0.04 and P: 0.01 vs. INTUITY Elite and Perceval). Perceval and INTUITY valves seem to provide a larger EOA-index (0.85 and 0.83 ± 0.1 cm 2 /m 2 ). Perceval valve is associated with the largest EOA and EOA-index, although the difference among the three prostheses was not statistically significant.
The largest Perceval EOA could possibly be explained by its implantation technique of radial expansion, that widens the annulus and maximizes the internal valve area. Each Perceval model covers a range of diameters. With this prosthesis, differently from the other two, oversizing of the valve is possible and frequent. In fact, in our series, we implanted not only S prostheses, but also M, L, and in one case even a Perceval XL. In some instances, oversizing was favored by incongruity between echocardiographic and anatomic annulus measurements. Echocardiographic imaging is limited, as it provides a two-dimensional aortic annulus diameter. However, in a more realistic three-dimensional view, we may recognize not a single aortic annulus, but rather the "anatomic annulus" (anatomic ventriculo-aortic junction), the "virtual annulus" (formed by the line joining the nadir point of each cusp), and the superior "surgical annulus" (crown-like ring). Complete radial expansion of an oversized Perceval valve would likely occupy the entire AVA, at the best adapting the prosthesis to the aortic root anatomy, obtaining in such a way a more physiological root reconstruction. On the other side, however, an oversized prosthesis presents a larger amount of cumbersome internal pericardial tissue, potentially flow obstructive if the prosthesis is not adequately expanded. The Perceval valve in our series was associated with better reverse LV mass reduction (−34.8%) as measured by a transthoracic echocardiogram. However, a significant difference with the other prostheses was not observed (P = 0.08). Although MRI may result more accurate than echocardiography in assessing left ventricular mass regression after AVR, 31 because of the higher cost its systematic use is still uncommon and often not available in retrospective studies. Therefore, a transthoracic echocardiogram is generally preferred and considered a reliable tool for evaluation of left ventricular mass regression.
At follow-up in all groups, absolute values were excellent in terms of clinical outcome and echocardiographic hemodynamic parameters. Incidence of moderate PPM was similar in the 3 groups (P = 0.2) and its occurrence didn't influence clinical outcome. Our data correlate with the abovementioned study of Mohty et al. 22 showing that moderate PPM is associated with increased morbidity and mortality only when left ventricular function is <50%. This was not our case, as in our series both early postoperative and follow-up, mean ejection fraction was >55%. Incidence of severe PPM was similar in the three groups (P = 0.7), with no mortality, no cases of NYHA >III, and no episodes of acute heart failure in those patients. However, our sample (5 patients) was too small in order to extrapolate a clear conclusion.
Limitations
This is a retrospective, nonrandomized study and because of restriction in the selection of patients (exclusion of combined procedures, reinterventions, patients <75 years old, and with severe aortic regurgitation), the number of cases in each group is quite exiguous. The study involved two centers with different surgeons and cardiologists. The absence of a core lab may have negatively affected the homogeneity of clinical and echocardiographic evaluation. Despite such limitations, we think that the present study may give some useful information on reliability of Trifecta, INTUITY, and Perceval when used in less favorable anatomical conditions such as small aortic annulus and on some apparently not clinically relevant differences detected among them.
Conclusions
At early and mid-term echocardiographic follow-up, AVR with Trifecta, INTUITY Elite, and Perceval prostheses in patients with small aortic annulus was associated with favorable results. The Trifecta valve is associated with significantly higher pressure gradients. The Perceval valve seems to provide the best left ventricular mass regression, but without reaching the statistical significance. Results obtained with all prostheses in terms of mortality, EOA, postoperative left ventricular mass reduction, freedom from congestive heart failure, incidence of paravalvular leaks, and endocarditis appear very satisfying, although longer follow-up and larger number of patients to better evaluate each prosthesis performance would be opportune.
